Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
Contacts Investor Relations Contact The Blueshirt Group Melanie Solomon, melanie@blueshirtgroup.com Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT)...